Brief Report: Patterns of Disease Progression with Durvalumab versus Placebo After Concurrent Chemoradiotherapy for Limited-Stage SCLC in the Phase 3 ADRIATIC Trial

Suresh Senan, Hongxia Cui, David R. Spigel, Byoung Chul Cho, Konstantin K. Laktionov, Yoshitaka Zenke, Ki Hyeong Lee, Alejandro Navarro, Yoshimasa Shiraishi, Sema Sezgin Goksu, Andrzej Badzio, Anhui Shi, Milada Zemanova, Niels Reinmuth, Puneeth Iyengar, Luis Paz-Ares, Huiling Xiong, W. Victoria Lai, Priti Chugh, Yuanbin Chen

Open source

DOI: 10.1016/j.jtho.2026.106221
Published: 2026-11
Container: Journal of Thoracic Oncology
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.jtho.2026.106221,
  title = {Brief Report: Patterns of Disease Progression with Durvalumab versus Placebo After Concurrent Chemoradiotherapy for Limited-Stage SCLC in the Phase 3 ADRIATIC Trial},
  author = {Suresh Senan and Hongxia Cui and David R. Spigel and Byoung Chul Cho and Konstantin K. Laktionov and Yoshitaka Zenke and Ki Hyeong Lee and Alejandro Navarro and Yoshimasa Shiraishi and Sema Sezgin Goksu and Andrzej Badzio and Anhui Shi and Milada Zemanova and Niels Reinmuth and Puneeth Iyengar and Luis Paz-Ares and Huiling Xiong and W. Victoria Lai and Priti Chugh and Yuanbin Chen},
  year = {2026},
  journal = {Journal of Thoracic Oncology},
  doi = {10.1016/j.jtho.2026.106221},
  url = {https://doi.org/10.1016/j.jtho.2026.106221}
}

RIS

TY  - JOUR
TI  - Brief Report: Patterns of Disease Progression with Durvalumab versus Placebo After Concurrent Chemoradiotherapy for Limited-Stage SCLC in the Phase 3 ADRIATIC Trial
AU  - Suresh Senan
AU  - Hongxia Cui
AU  - David R. Spigel
AU  - Byoung Chul Cho
AU  - Konstantin K. Laktionov
AU  - Yoshitaka Zenke
AU  - Ki Hyeong Lee
AU  - Alejandro Navarro
AU  - Yoshimasa Shiraishi
AU  - Sema Sezgin Goksu
AU  - Andrzej Badzio
AU  - Anhui Shi
AU  - Milada Zemanova
AU  - Niels Reinmuth
AU  - Puneeth Iyengar
AU  - Luis Paz-Ares
AU  - Huiling Xiong
AU  - W. Victoria Lai
AU  - Priti Chugh
AU  - Yuanbin Chen
PY  - 2026
JO  - Journal of Thoracic Oncology
DO  - 10.1016/j.jtho.2026.106221
UR  - https://doi.org/10.1016/j.jtho.2026.106221
ER  -

APA

Senan, S., Cui, H., Spigel, D. R., Cho, B. C., Laktionov, K. K., Zenke, Y., Lee, K. H., Navarro, A., Shiraishi, Y., Goksu, S. S., Badzio, A., Shi, A., Zemanova, M., Reinmuth, N., Iyengar, P., Paz-Ares, L., Xiong, H., Lai, W. V., Chugh, P., & Chen, Y. (2026). Brief Report: Patterns of Disease Progression with Durvalumab versus Placebo After Concurrent Chemoradiotherapy for Limited-Stage SCLC in the Phase 3 ADRIATIC Trial. Journal of Thoracic Oncology. https://doi.org/10.1016/j.jtho.2026.106221

Source records

crossref · retrieved 2026-11-04T02:34:14.782Z